Latest Form 4 insider transactions

Barbara Trebbi, a Director of Bausch & Lomb Corp, received 11,776 shares of common stock on August 12, 2026.

Velchamy Sankarlingam, Pres. of Engineering & Product of Zoom Communications, Inc., sold 7,644 shares of common stock on July 15, 2026 for $91.98 per share.

Sam Levinson, a Director and 10% owner of Clipper Realty Inc., purchased 154,764 shares of common stock on August 12, 2026.

Rhea J Posedel, a Director of Aehr Test Systems, sold 5,973 shares of common stock on August 14, 2026 for $140.00 per share.

Peter M Castleman, a Director of Caris Life Sciences, Inc., received 13,192 shares of common stock on August 14, 2026.

Third Rock Ventures V, L.P. and 5 others reported changes in beneficial ownership of Septerna, Inc. common stock on August 12, 2026.

T Danny Phillips, a Director of Caris Life Sciences, Inc., received 13,192 shares of common stock on August 14, 2026.

Arjun Agarwal, Senior Vice President, Finance of Oruka Therapeutics, Inc., sold 10,000 shares of common stock on August 13, 2026.

Lloyd Minor, a Director of Caris Life Sciences, Inc., received 13,192 shares of common stock on August 14, 2026.

Joseph E Gilliam, a Director of Caris Life Sciences, Inc., received 13,192 shares of common stock on August 14, 2026.

Sachin Jain, Chief Operating Officer of CoreWeave, Inc., sold 1 shares of common stock on August 12, 2026 for $110.00 per share.

David Paul Fredrickson, a Director of Caris Life Sciences, Inc., received 13,192 shares of common stock on August 14, 2026.

Jeff L Vacirca, a Director of Caris Life Sciences, Inc., received 13,192 shares of common stock on August 14, 2026.

Laura I Johansen, a Director of Caris Life Sciences, Inc., received 13,192 shares of common stock on August 14, 2026.

Brian Charles Shackley, SVP, Chief Accounting Officer of AeroVironment Inc, sold 205 shares of common stock on August 14, 2026 for $201.86 per share.

Jon Halbert, a Director of Caris Life Sciences, Inc., received 13,192 shares of common stock on August 14, 2026.

AJB Investment Fund II, LP and 3 others reported changes in beneficial ownership of Jewett Cameron Trading Co Ltd common stock on August 12, 2026.

Laurence E Paul, a Director of Bausch & Lomb Corp, received 11,776 shares of common stock on August 12, 2026.

Ping Tak Wu, VP, U.S. Operations of Gsi Technology Inc, received 30,000 shares of common stock on August 13, 2026.

Matthew Kalish, a Director of DraftKings Inc., reported multiple transactions in common stock on August 12, 2026.

Trecia M Canty, SVP and General Counsel of PBF Energy Inc., sold 140,320 shares of common stock on August 12, 2026.

Mark James King, Exec Chairman & Interim CEO and a Director of Jack In The Box Inc, sold 5,647 shares of common stock on August 14, 2026 for $18.59 per share.

Avidan Akerib, VP, Associative Computing of Gsi Technology Inc, received 40,000 shares of common stock on August 13, 2026.

Plum Acquisition Corp. III announces the resignation of its independent registered public accounting firm, Marcum LLP, effective June 3, 2026, following the acquisition of Marcum's attest business by CBIZ CPAs P.C.

Plum Acquisition Corp. III announces the resignation of its independent registered public accounting firm, Marcum LLP, effective June 3, 2026, following the acquisition of Marcum's attest business by CBIZ CPAs P.C.

Robert J Chersi, a Director of Bausch & Lomb Corp, received 11,776 shares of common stock on August 12, 2026.

Lee-Lean Shu, Pres., CEO and Chairman and a Director of Gsi Technology Inc, reported multiple transactions in common stock on August 13, 2026.

Ctt Pharmaceutical Holdings, Inc. reported changes in beneficial ownership of Ctt Pharmaceutical Holdings, Inc. common stock on August 12, 2026.

Michael Conklin, EVP & CHRO of Ryan Specialty Holdings, Inc., sold 2,043 shares of common stock on August 13, 2026 for $42.26 per share.

Set Fui Chong, Chief Financial Officer of BioNexus Gene Lab Corp, received 96,774 shares of common stock on August 13, 2026.